US Trustee Calls Teligent Ch. 11 Plan Releases 'Baffling'
The U.S. Trustee's Office on Monday urged a Delaware bankruptcy judge to reject generic pharmaceutical maker Teligent Inc.'s Chapter 11 plan disclosures, saying the statement provides a "baffling" explanation of impermissible,...To view the full article, register now.
Already a subscriber? Click here to view full article